Safety and effectiveness of bivalirudin in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis

Safety and effectiveness of bivalirudin in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis

Recent clinical trials have shown that while bivalirudin exhibits similar efficacy with heparin, it offers several advantages over heparin, such as a better safety profile. We aimed to evaluate the efficacy and safety of bivalirudin use during Percutaneous Coronary Intervention (PCI) in the treatmen...

Full description

Bibliographic Details
Main Authors: Abdullah, A.H (Author), Ajmi, N.N (Author), Dali, A.F (Author), Hamdi, A.H.A (Author), Khan, T.M (Author), Ming, L.C (Author), Neoh, C.F (Author), Nuri, T.H.M (Author), Saleh, M.S (Author)
Format: Article
Language:English
Published: Frontiers Media S.A. 2017
Subjects:
acute coronary syndrome
Acute coronary syndrome
angina pectoris
anticoagulant therapy
bivalirudin
bleeding
blood clot lysis
cardiovascular mortality
cerebrovascular accident
confidence interval
data extraction
drug efficacy
drug safety
fibrinogen receptor antagonist
Glycoprotein IIb/IIIa inhibitor
heart infarction
heparin
human
Ischemic events
Major bleeding
meta analysis
Myocardial infarction
outcome assessment
patient selection
percutaneous coronary intervention
Percutaneous coronary intervention
quality control
randomized controlled trial (topic)
revascularization
Review
risk factor
stent thrombosis
Stent thrombosis
Stroke
systematic review
treatment outcome
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items